Breaking: Vivos Therapeutics Strikes Deals; RPM Beats Wall Street Estimates
- October 04th, 2023
- 373 views
Shares of Vivos Therapeutics, Inc. (Nasdaq: VVOS) surged by more than 40% in pre-market trading following the announcement of strategic agreements with Ormco and On Demand Orthodontist. These agreements pave the way for Spark Clear Aligners to be offered within Vivos' national network of providers.
Vivos anticipates that these new relationships will not only bring potentially significant revenue opportunities for the company but also provide valuable airway-focused expertise. Additionally, Vivos-trained providers may benefit from potential cost savings.
$VVOS was trading at $0.27 in pre-market, marking a notable increase of $0.08 (+45.69%).
In other news, RPM International Inc. (NYSE: RPM) posted first-quarter fiscal 2024 earnings of $1.64 per share, surpassing the consensus EPS estimate of $1.55. The company's quarterly sales totaled $2.01 billion, exceeding analysts' revenue expectations of $1.97 billion.
In pre-market, $RPM was trading at $98.93, up $6.13 (6.61%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Earnings Countdown: Lockheed Martin, Stryker, and PACCAR Gear Up
January 26th, 2025Earnings Spotlight: SoFi Technologies, Sanmina, and Nucor Set to Report
January 26th, 2025Global Flag Football League Plans To Host Pro Flag Football Tournament in Las Vegas
January 23rd, 2025Earnings On Deck: Netflix, United Airlines, and Agilysys Gear Up
January 19th, 2025
Member Login